Mr. Samira Sakhia reports

NOTICE OF KNIGHT THERAPEUTICS' THIRD QUARTER 2023 RESULTS CONFERENCE CALL

Knight Therapeutics Inc. will release its third quarter 2023 financial results on Thursday, Nov. 9, 2023, prior to market opening. Following the release, Knight will hold a conference call and audio webcast. Knight cordially invites all interested parties to participate in this call.

Date:  Thursday, Nov. 9, 2023

Time:  8:30 a.m. ET

Telephone:  1-888-664-6383 (toll-free) or 1-416-764-8650 (international)

Webcast:  available on-line

This is a listen-only audio webcast. Media Player is required to listen to the broadcast.

Replay:  An archived replay will be available for 30 days on the company's website.

About Knight Therapeutics Inc.

Knight Therapeutics, headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing and commercializing pharmaceutical products for Canada and Latin America.

We seek Safe Harbor.